A high-throughput, automated, cell-free expression and screening platform for antibody discovery
Preprint
Abstract
Antibody discovery is bottlenecked by the individual expression and evaluation of antigen-specific hits. Here, we address this gap by developing an automated workflow combining cell-free DNA template generation, protein synthesis, and high-throughput binding measurements of antibody fragments in a process that takes hours rather than weeks. We apply this workflow to 119 published SARS-CoV-2 neutralizing antibodies and demonstrate rapid identification of the most potent antibody candidates.Keywords
This publication has 49 references indexed in Scilit:
- ‘Zipbody’ leucine zipper-fused Fab inE. coli in vitroandin vivoexpression systemsProtein Engineering, Design and Selection, 2016
- A simplified and robust protocol for immunoglobulin expression in Escherichia coli cell‐free protein synthesis systemsBiotechnology Progress, 2015
- Cell-Free Synthesis Meets Antibody Production: A ReviewAntibodies, 2015
- Engineering toward a bacterial “endoplasmic reticulum” for the rapid expression of immunoglobulin proteinsmAbs, 2014
- Linear DNA for Rapid Prototyping of Synthetic Biological Circuits in an Escherichia coli Based TX-TL Cell-Free SystemACS Synthetic Biology, 2013
- Enhancing multiple disulfide bonded protein folding in a cell‐free systemBiotechnology and Bioengineering, 2004
- Efficient production of a bioactive, multiple disulfide‐bonded protein using modified extracts of Escherichia coliBiotechnology and Bioengineering, 2003
- Conversion of a Peroxiredoxin into a Disulfide Reductase by a Triplet Repeat ExpansionScience, 2001
- Functional antibody production using cell-free translation: Effects of protein disulfide isomerase and chaperonesNature Biotechnology, 1997
- Humanization of an anti-p185HER2 antibody for human cancer therapy.Proceedings of the National Academy of Sciences, 1992